These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells. Kishihara M, Nakao Y, Baba Y, Kobayashi N, Matsukura S, Kuma K, Fujita T. J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672 [Abstract] [Full Text] [Related]
6. [Clinical relevance of the determination of TSH-binding inhibitory immunoglobulins (TBII) in patients with immunogenic hyperthyroidism in methimazole therapy]. Heberling HJ, Bierwolf B, Kuhlmann E, Klugmann T, Dietel P, Fischer S. Dtsch Z Verdau Stoffwechselkr; 1987 Apr; 47(6):331-6. PubMed ID: 2896115 [Abstract] [Full Text] [Related]
7. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease. Hovens GC, Buiting AM, Karperien M, Ballieux BE, van der Pluijm G, Pereira AM, Romijn JA, Smit JW. Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516 [Abstract] [Full Text] [Related]
8. [Behavior of TBII (TSH receptor binding immunoglobulins) in multinodular struma]. Sussi PL, Burro A, Dagradi V, Abrescia F, Patuzzo E, Degara A. Chir Ital; 1987 Dec; 39(6):527-32. PubMed ID: 2895687 [Abstract] [Full Text] [Related]
9. Thyrotropin binding inhibiting immunoglobulins (TBII) in Graves' disease, toxic nodular goitre and autoimmune thyroiditis. Wägar G, Mäkinen T, Lamberg BA, Gordin A, Apter L, Pekonen F. Ann Clin Res; 1982 Apr; 14(2):83-9. PubMed ID: 6184007 [Abstract] [Full Text] [Related]
14. Thyroid-stimulating immunoglobulins in Hashimoto's thyroiditis measured by radioreceptor assay and adenylate cyclase stimulation and their relationship to HLA-D alleles. Bliddal H, Bech K, Feldt-Rasmussen U, Thomsen M, Ryder LP, Hansen JM, Siersbaek-Nielsen K, Friis T. J Clin Endocrinol Metab; 1982 Nov; 55(5):995-8. PubMed ID: 6126490 [Abstract] [Full Text] [Related]
15. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies. Eckstein AK, Plicht M, Lax H, Hirche H, Quadbeck B, Mann K, Steuhl KP, Esser J, Morgenthaler NG. Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965 [Abstract] [Full Text] [Related]
16. Effect of solubilization of porcine thyrotropin (TSH) receptor on TSH binding and on radio-receptor assay for anti-TSH receptor antibodies. Watanabe Y, Tada H, Hidaka Y, Takano T, Amino N. Biochem Biophys Res Commun; 1998 Jul 09; 248(1):110-4. PubMed ID: 9675095 [Abstract] [Full Text] [Related]
17. Loss of variability in Graves' disease: stimulatory TSH-receptor antibodies bind to the TSH-receptor in a continued, non-pulsatile and non-chaotic fashion. Schuppert F, Diegelmann B, Geest T, Wagner TO, von zur Mühlen A. Chronobiologia; 1994 Jul 09; 21(1-2):21-32. PubMed ID: 7924634 [Abstract] [Full Text] [Related]
18. Thyrotropin receptor-adenylate cyclase function in human thyroid neoplasms. Saltiel AR, Powel-Jones CH, Thomas CG, Nayfeh SN. Cancer Res; 1981 Jun 09; 41(6):2360-5. PubMed ID: 6263464 [Abstract] [Full Text] [Related]
19. Protein-A purified human immunoglobulins: a comparison of thyroid stimulating and thyrotrophin receptor binding activities in thyrotoxicosis. Reader SC, Davison B, Beardwell C, Ratcliffe JG, Robertson WR. Clin Endocrinol (Oxf); 1986 Oct 09; 25(4):441-51. PubMed ID: 2887306 [Abstract] [Full Text] [Related]
20. Thyrotrophin binding inhibition by anti-thyrotrophin receptor antibodies in Graves' disease which is not reflected by 1.6 M ammonium sulphate precipitates. de Bruin TW, Van der Heide D, Querido A. Clin Endocrinol (Oxf); 1982 Jul 01; 17(1):77-84. PubMed ID: 6126284 [Abstract] [Full Text] [Related] Page: [Next] [New Search]